$105.02
-0.33-0.31%
In chiusura: Nov 26, 4:00 PM EST
$104.87
-0.15-0.14%
After hour: 5:29 PM EST
Comments
Loading...
Attività di insider trading
Tieni traccia delle ultime attività di insider trading Medtronic. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Medtronic.
Cos'è l'attività interna?
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Cosa stanno facendo gli Medtronic PLC addetti ai lavori?
A Medtronic PLC, la recente attività interna ha attirato l'attenzione. Negli ultimi 30 giorni, gli addetti ai lavori hanno riferito di aver venduto un totale di 30.00K azioni del valore di $3.06M, nel frattempo, gli addetti ai lavori hanno segnalare nessun acquisto negli ultimi 30 giorni.
Notevoli acquisti e vendite recenti di insider
- Il giorno settembre 5, 2025, SKIP HARRY KIIL, l'azienda EVP & PRESIDENT CARDIOVASCULAR sold 8.61K condivisioni per $91.58 ciascuna.
- Il giorno novembre 21, 2025, Gregory Smith, l'azienda EVP GLOBAL OPS & SUPPLY CHAIN sold 30K condivisioni per $101.95 ciascuna.
Statistiche sulla proprietà per Medtronic PLC
Numero di azioni emesse
1.283B
Azioni possedute dagli insider
6.805M
Percentuale posseduta dagli Insider
0.53%
Azioni possedute dagli investitori istituzionali
768.752M
Percentuale posseduta dagli investitori istituzionali
59.9%
Nov 21, 2025 | EVP GLOBAL OPS & SUPPLY CHAIN | -30.00K | $101.95 | -$3.06M | SELL | -39.47% | 46.02K | Nov 19 | ||
Sep 05, 2025 | EVP & PRESIDENT CARDIOVASCULAR | -8.61K | $91.58 | -$788.05K | SELL | -19.46% | 35.62K | Sep 03 | ||
Aug 25, 2025 | DIRECTOR | 5.00K | $92.55 | $462.75K | BUY | ∞ | 5.00K | Aug 22 - Aug 25 | ||
Jan 27, 2025 | EVP & PRES NEUROSCIENCE | 0.00 | $84.00 | -$149.24K | SELL-OPTIONS | 0.00% | 40.98K | Jan 24 | ||
Jan 10, 2025 | EVP & PRES NEUROSCIENCE | -3.00K | $77.63 | -$279.38K | SELL | -6.86% | 40.71K | Jan 08 | ||
Jun 11, 2024 | CHAIRMAN AND CEO | 0.00 | $73.26 | -$401.47K | SELL-OPTIONS | 0.00% | 143.35K | Jun 07 | ||
Apr 09, 2024 | EVP & PRESIDENT, SURGICAL OU | -854.00 | $83.14 | -$71.00K | SELL | -2.97% | 27.93K | Apr 08 | ||
Feb 23, 2024 | EVP & PRESIDENT CARDIOVASCULAR | 0.00 | $77.10 | -$492.93K | SELL-OPTIONS | 0.00% | 48.29K | Feb 21 | ||
Dec 20, 2023 | EVP & PRES NEUROSCIENCE | -5.00K | $82.17 | -$410.60K | SELL | -14.74% | 28.91K | Dec 19 | ||
Aug 25, 2023 | EVP GLOBAL OPS & SUPPLY CHAIN | -10.00K | $83.84 | -$838.40K | SELL | -17.63% | 46.72K | Aug 23 | ||
Aug 16, 2023 | EVP & PRES NEUROSCIENCE | -1.00K | $83.38 | -$83.38K | SELL | -2.89% | 33.57K | Aug 14 | ||
Aug 07, 2023 | EVP & PRESIDENT, SURGICAL OU | -979.00 | $84.30 | -$225.50K | SELL | -3.27% | 28.93K | Aug 03 - Aug 04 | ||
Jul 18, 2023 | EVP & PRES NEUROSCIENCE | -2.00K | $87.97 | -$175.94K | SELL | -7.71% | 23.95K | Jul 14 | ||
Jul 12, 2023 | EVP AND PRES. GLOBAL REGIONS | 0.00 | $70.95 | -$172.39K | SELL-OPTIONS | 0.00% | 43.80K | Jul 10 | ||
Dec 16, 2022 | EVP & PRESIDENT CARDIOVASCULAR | 0.00 | $67.91 | -$418.71K | SELL-OPTIONS | 0.00% | 36.09K | Dec 13 | ||
Oct 17, 2022 | EVP AND PRES. GLOBAL REGIONS | 0.00 | $61.57 | -$96.01K | SELL-OPTIONS | 0.00% | 43.48K | Oct 14 | ||
Mar 21, 2022 | EVP & CHIEF FINANCIAL OFFICER | -682.00 | $110.00 | -$75.02K | SELL | -0.80% | 84.81K | Mar 18 | ||
Mar 14, 2022 | SVP, CHIEF HR OFFICER | -6.00K | $105.30 | -$631.80K | SELL | -17.10% | 29.08K | Mar 11 | ||
Dec 27, 2021 | EVP & PRES. MEDICAL SURGICAL | -7.22K | $102.04 | -$736.52K | SELL | -14.99% | 40.93K | Dec 23 | ||
Dec 17, 2021 | DIRECTOR | 5.01K | $103.26 | $517.33K | BUY | 4.63% | 113.17K | Dec 16 | ||
Dec 07, 2021 | EVP & CHIEF FINANCIAL OFFICER | -682.00 | $110.00 | -$75.02K | SELL | -1.84% | 36.29K | Dec 06 | ||
Oct 01, 2021 | SVP GENERAL COUNSEL & CORP SEC | 0.00 | $102.29 | -$2.39M | SELL-OPTIONS | 0.00% | 48.76K | Sep 30 | ||
Sep 01, 2021 | SVP GENERAL COUNSEL & CORP SEC | 0.00 | $104.50 | -$3.01M | SELL-OPTIONS | 0.00% | 48.76K | Aug 31 | ||
Aug 26, 2021 | EVP & PRES DIABETES/CARDIOVASC | 0.00 | $86.40 | -$2.71M | SELL-OPTIONS | 0.00% | 33.33K | Aug 25 | ||
Aug 26, 2021 | CEO | 0.00 | $97.24 | -$820.65K | SELL-OPTIONS | 0.00% | 95.84K | Aug 25 | ||
Aug 04, 2021 | SVP GENERAL COUNSEL & CORP SEC | -3.43K | $131.40 | -$1.24M | SELL | -6.57% | 48.76K | Aug 02 | ||
Jun 30, 2021 | CEO | 0.00 | $90.31 | -$804.65K | SELL-OPTIONS | 0.00% | 81.95K | Jun 28 | ||
Jun 22, 2021 | EVP & PRES NEUROSCIENCE | 115.00 | $99.05 | -$42.38K | SELL-OPTIONS | 0.54% | 21.60K | Jun 18 - Jun 21 | ||
Jun 17, 2021 | EVP & CHIEF FINANCIAL OFFICER | -605.00 | $124.47 | -$75.30K | SELL | -0.69% | 86.83K | Jun 15 | ||
Jun 02, 2021 | EVP & PRES NEUROSCIENCE | 2.47K | $86.98 | -$669.69K | SELL-OPTIONS | 13.00% | 21.49K | May 28 - Jun 01 | ||
Jun 01, 2021 | EVP & PRESIDENT AMERICAS | 0.00 | $104.69 | -$1.52M | SELL-OPTIONS | 0.00% | 42.55K | May 28 | ||
Apr 07, 2021 | CEO | 0.00 | $85.67 | -$776.81K | SELL-OPTIONS | 0.00% | 81.94K | Apr 05 | ||
Mar 16, 2021 | EVP & CHIEF FINANCIAL OFFICER | -632.00 | $119.12 | -$75.28K | SELL | -0.72% | 87.16K | Mar 15 | ||
Mar 03, 2021 | EVP & PRESIDENT EMEA | 0.00 | $76.43 | -$595.66K | SELL-OPTIONS | 0.00% | 43.80K | Mar 02 | ||
Dec 30, 2020 | — | -15.00K | $114.90 | -$1.72M | SELL | -30.18% | 34.71K | Dec 28 | ||
Dec 23, 2020 | — | -2.60K | $115.56 | -$301.03K | SELL | -4.81% | 51.54K | Dec 22 | ||
Dec 21, 2020 | — | -10.93K | $115.46 | -$1.26M | GIFT | -19.57% | 44.92K | Dec 16 - Dec 18 | ||
Dec 16, 2020 | — | -670.00 | $114.33 | -$76.60K | SELL | -0.76% | 87.50K | Dec 15 | ||
Nov 10, 2020 | — | 0.00 | $87.94 | -$1.04M | OPTION EXERCISE | 0.00% | 54.15K | Nov 09 | ||
Oct 14, 2020 | — | -763.00 | $108.40 | -$82.71K | GIFT | -0.13% | 589.44K | Oct 09 | ||
Oct 09, 2020 | — | 0.00 | $86.38 | -$978.53K | OPTION EXERCISE | 0.00% | 54.33K | Oct 08 | ||
Oct 09, 2020 | — | 4.61K | $108.52 | $499.95K | PURCHASE | 4.52% | 106.47K | Oct 08 | ||
Sep 25, 2020 | — | -9.58K | $104.34 | -$999.99K | SELL | -18.06% | 43.48K | Sep 23 | ||
Sep 16, 2020 | — | -702.00 | $107.78 | -$75.66K | SELL | -0.79% | 87.97K | Sep 15 | ||
Sep 11, 2020 | — | -9.56K | $105.05 | -$1.00M | SELL | -15.27% | 53.06K | Sep 09 | ||
Jun 02, 2020 | — | -2.00K | $97.72 | -$195.44K | SELL | -4.05% | 47.44K | May 29 | ||
Feb 24, 2020 | — | 8.77K | $113.68 | $997.09K | PURCHASE | 1.46% | 611.09K | Feb 20 | ||
Dec 26, 2019 | SVP & CHIEF MEDICAL & SCIENCE | -8.09K | $84.06 | -$3.44M | SELL | -10.22% | 71.01K | Dec 24 | ||
Dec 09, 2019 | DIRECTOR | 5.00K | $113.29 | $566.45K | BUY | 5.54% | 95.26K | Dec 06 | ||
Dec 03, 2019 | EVP & PRESIDENT MITG | 0.00 | $85.94 | -$2.58M | SELL-OPTIONS | 0.00% | 52.07K | Dec 02 | ||
Nov 18, 2019 | EVP & GROUP PRES, CARDIAC&VASC | 0.00 | $75.03 | -$2.67M | SELL-OPTIONS | 0.00% | 192.37K | Nov 15 | ||
Nov 15, 2019 | EVP & GROUP PRES, CARDIAC&VASC | 0.00 | $75.09 | -$145.80K | SELL-OPTIONS | 0.00% | 192.37K | Nov 14 | ||
Nov 04, 2019 | EVP & PRESIDENT MITG | 0.00 | $72.83 | -$3.81M | SELL-OPTIONS | 0.00% | 52.07K | Nov 01 | ||
Nov 04, 2019 | EVP & GROUP PRES, CARDIAC&VASC | 0.00 | $74.20 | -$2.75M | SELL-OPTIONS | 0.00% | 192.37K | Nov 01 | ||
Sep 30, 2019 | SVP & CHIEF MEDICAL & SCIENCE | -21.43K | $107.51 | -$2.30M | SELL | -21.37% | 78.82K | Sep 27 | ||
Sep 12, 2019 | EVP & GROUP PRESIDENT DIABETES | -10.00K | $96.51 | -$2.65M | SELL | -24.53% | 30.76K | Sep 10 | ||
Aug 06, 2019 | SVP GENERAL COUNSEL & CORP SEC | -4.00K | $100.31 | -$401.24K | SELL | -7.03% | 52.91K | Aug 05 | ||
Aug 02, 2019 | SVP GENERAL COUNSEL & CORP SEC | -12.13K | $102.18 | -$1.24M | SELL | -17.57% | 56.91K | Aug 01 - Aug 02 | ||
Aug 02, 2019 | SVP & CHIEF MEDICAL & SCIENCE | -10.51K | $102.18 | -$1.07M | SELL | -9.49% | 100.24K | Aug 01 - Aug 02 | ||
Jul 23, 2019 | SVP & CHIEF MEDICAL & SCIENCE | -3.44K | $101.12 | -$347.65K | SELL | -3.32% | 100.13K | Jul 22 | ||
Jun 18, 2019 | SVP, CHIEF HR OFFICER | -9.00K | $97.66 | -$878.98K | SELL | -20.11% | 35.76K | Jun 17 | ||
Jun 14, 2019 | EVP & GROUP PRESIDENT DIABETES | -20.93K | $87.75 | -$2.66M | SELL | -32.91% | 42.67K | Jun 12 | ||
Jun 07, 2019 | EVP & GROUPPRES RESTORA THERAP | -11.00K | $96.05 | -$1.06M | SELL | -18.36% | 48.92K | Jun 06 | ||
May 29, 2019 | EVP & PRESIDENT EMEA | -9.00K | $91.88 | -$826.92K | SELL | -13.28% | 58.78K | May 28 | ||
May 28, 2019 | DIRECTOR | 10.90K | $92.40 | $1.01M | BUY | 13.79% | 89.94K | May 24 | ||
Jan 09, 2019 | EVP & CHIEF FINANCIAL OFFICER | 3.00K | $83.87 | $251.61K | BUY | 3.72% | 83.68K | Jan 09 | ||
Jan 09, 2019 | CHAIRMAN & CEO | 12.00K | $84.05 | $1.01M | BUY | 2.11% | 580.72K | Jan 09 | ||
Sep 25, 2018 | EVP & GROUPPRES RESTORA THERAP | 0.00 | $67.24 | -$3.06M | SELL-OPTIONS | 0.00% | 59.20K | Sep 24 | ||
Sep 05, 2018 | EVP & GROUP PRESIDENT DIABETES | 0.00 | $79.52 | -$877.06K | SELL-OPTIONS | 0.00% | 62.65K | Aug 31 | ||
Aug 29, 2018 | SVP & CHIEF MEDICAL & SCIENCE | -5.95K | $67.34 | -$2.92M | SELL | -5.34% | 105.40K | Aug 28 | ||
Aug 24, 2018 | DIRECTOR | 1.27K | $65.82 | -$148.71K | SELL-OPTIONS | 2.12% | 60.96K | Aug 23 | ||
Aug 23, 2018 | DIRECTOR | 2.60K | $95.88 | $249.29K | BUY | 3.50% | 76.94K | Aug 23 | ||
Aug 23, 2018 | EVP & GROUP PRES, CARDIAC&VASC | 32.67K | $66.25 | -$7.30M | SELL-OPTIONS | 19.04% | 204.28K | Aug 22 | ||
Jun 12, 2018 | SVP GENERAL COUNSEL & CORP SEC | -8.91K | $86.82 | -$773.57K | SELL | -14.67% | 51.84K | Jun 11 | ||
Jun 11, 2018 | SVP & CHIEF MEDICAL & SCIENCE | -11.50K | $87.13 | -$1.00M | SELL | -9.79% | 105.92K | Jun 08 | ||
Mar 14, 2018 | DIRECTOR | 284.00 | $66.95 | -$29.08K | SELL-OPTIONS | 0.61% | 47.03K | Mar 13 | ||
Mar 06, 2018 | SVP, CHIEF HR OFFICER | -16.20K | $69.66 | -$2.21M | SELL | -29.39% | 38.91K | Mar 02 - Mar 05 | ||
Jan 10, 2018 | SRVP & CHIEF SCIEN, CLIN, REG | 2.84K | $61.12 | -$3.84M | SELL-OPTIONS | 2.48% | 117.11K | Jan 09 | ||
Jan 08, 2018 | EVP & GROUP PRESIDENT DIABETES | 0.00 | $73.88 | -$581.75K | SELL-OPTIONS | 0.00% | 65.83K | Jan 05 | ||
Dec 18, 2017 | EVP, PRESIDENT, MITG | -16.00K | $82.82 | -$1.33M | SELL | -15.26% | 88.82K | Dec 15 | ||
Nov 17, 2017 | EVP, PRESIDENT, MITG | -16.00K | $79.02 | -$1.26M | SELL | -12.79% | 109.07K | Nov 16 | ||
Oct 16, 2017 | EVP, PRESIDENT, MITG | -16.00K | $78.03 | -$1.25M | SELL | -11.38% | 124.56K | Oct 16 | ||
Sep 18, 2017 | CHAIRMAN & CEO | -40.41K | $60.22 | -$7.58M | SELL | -6.96% | 540.29K | Sep 15 | ||
Jul 18, 2017 | EVP, PRESIDENT, MITG | -12.00K | $88.57 | -$1.06M | SELL | -8.06% | 136.91K | Jul 17 | ||
Jun 21, 2017 | DIRECTOR | 5.60K | $88.90 | $497.84K | BUY | 8.44% | 71.94K | Jun 21 | ||
Mar 21, 2017 | EVP & PRESIDENT EMEA | 0.00 | $64.34 | -$1.75M | SELL-OPTIONS | 0.00% | 51.24K | Mar 20 | ||
Mar 17, 2017 | CHAIRMAN & CEO | -20.00K | $60.82 | -$4.96M | SELL | -3.50% | 550.62K | Mar 15 | ||
Mar 06, 2017 | EVP & GROUP PRESIDENT DIABETES | 0.00 | $72.54 | -$1.02M | SELL-OPTIONS | 0.00% | 58.93K | Mar 02 | ||
Dec 14, 2016 | DIRECTOR | 13.66K | $73.21 | $999.98K | BUY | 25.50% | 67.22K | Dec 13 | ||
Nov 23, 2016 | DIRECTOR | 2.00K | $73.27 | $146.53K | BUY | 5.23% | 40.25K | Nov 23 | ||
Sep 28, 2016 | SRVP & CHIEF SCIEN, CLIN, REG | -11.72K | $61.30 | -$2.57M | SELL | -9.86% | 107.08K | Sep 26 - Sep 27 | ||
Sep 19, 2016 | DIRECTOR | 2.15K | $64.94 | -$228.53K | SELL-OPTIONS | 7.91% | 29.38K | Sep 15 | ||
Sep 19, 2016 | CHAIRMAN & CEO | -61.92K | $84.93 | -$5.26M | SELL | -9.86% | 565.92K | Sep 15 | ||
Aug 31, 2016 | EVP, PRESIDENT, MITG | 0.00 | $58.26 | -$862.20K | SELL-OPTIONS | 0.00% | 153.19K | Aug 29 | ||
Jul 27, 2016 | EVP, PRESIDENT, MITG | 0.00 | $58.26 | -$862.20K | SELL-OPTIONS | 0.00% | 93.72K | Jul 26 | ||
Jul 19, 2016 | EVP & GROUPPRES RESTORA THERAP | -3.77K | $88.26 | -$332.40K | SELL | -12.54% | 26.27K | Jul 15 | ||
Jul 14, 2016 | EVP & GLOBAL OPS AND IT | 5.57K | $68.67 | -$1.15M | SELL-OPTIONS | 3.04% | 188.79K | Jul 13 | ||
Jul 14, 2016 | DIRECTOR | 496.00 | $69.98 | -$53.09K | SELL-OPTIONS | 1.48% | 33.99K | Jul 13 | ||
Jul 08, 2016 | SVP, CHIEF HR OFFICER | -9.79K | $87.08 | -$852.27K | SELL | -13.90% | 60.63K | Jul 06 | ||
Jul 06, 2016 | EVP, PRESIDENT, MITG | 0.00 | $57.20 | -$913.57K | SELL-OPTIONS | 0.00% | 93.72K | Jul 05 | ||
Jun 07, 2016 | SRVP & CHIEF SCIEN, CLIN, REG | 8.99K | $61.67 | -$1.72M | SELL-OPTIONS | 8.60% | 113.61K | Jun 03 | ||
Jun 03, 2016 | EVP & PRESIDENT EMEAC | -1.68K | $58.27 | -$599.37K | SELL | -5.16% | 30.94K | Jun 01 | ||
Apr 05, 2016 | SRVP & CHIEF SCIEN, CLIN, REG | -4.00K | $75.22 | -$300.88K | SELL | -3.69% | 104.36K | Apr 01 | ||
Mar 22, 2016 | DIRECTOR | 255.00 | $61.25 | -$23.56K | SELL-OPTIONS | 0.82% | 31.30K | Mar 18 | ||
Mar 21, 2016 | CHAIRMAN & CEO | -23.80K | $76.15 | -$1.81M | SELL | -3.81% | 600.74K | Mar 17 | ||
Mar 08, 2016 | EVP, PRESIDENT, MITG | -5.00K | $75.00 | -$375.00K | SELL | -4.91% | 96.81K | Mar 04 | ||
Feb 08, 2016 | EVP, PRESIDENT, MITG | -5.00K | $76.14 | -$380.70K | SELL | -4.68% | 101.81K | Feb 05 | ||
Jan 11, 2016 | EVP & PRES MIN INVAS THERAPIES | -5.00K | $75.00 | -$375.00K | SELL | -4.48% | 106.51K | Jan 08 | ||
Dec 08, 2015 | SRVP & CHIEF SCIEN, CLIN, REG | 1.69K | $63.38 | -$320.61K | SELL-OPTIONS | 1.58% | 108.09K | Dec 04 | ||
Sep 16, 2015 | CHAIRMAN & CEO | -20.00K | $69.43 | -$1.39M | SELL | -3.66% | 526.82K | Sep 15 | ||
Jul 16, 2015 | SVP, CHIEF HR OFFICER | -5.48K | $66.74 | -$565.56K | SELL | -7.48% | 67.79K | Jul 14 | ||
Apr 07, 2015 | SRVP & CHIEF SCIEN, CLIN, REG | 3.68K | $66.20 | -$508.54K | SELL-OPTIONS | 3.77% | 101.33K | Apr 06 | ||
Mar 27, 2015 | EVP & CHIEF FINANCIAL OFFICER | -6.17K | $67.28 | -$1.26M | SELL | -3.45% | 172.70K | Mar 25 | ||
Mar 20, 2015 | EVP & PRESIDENT EMEAC | -7.62K | $77.41 | -$589.79K | SELL | -25.40% | 22.37K | Mar 18 | ||
Mar 17, 2015 | CHAIRMAN & CEO | -20.00K | $76.24 | -$1.52M | SELL | -3.48% | 554.40K | Mar 13 | ||
Mar 02, 2015 | — | -368.00 | $78.85 | -$29.02K | SELL | -0.90% | 40.61K | Feb 26 | ||
Feb 20, 2015 | EVP & GROUPPRES RESTORA THERAP | -1.85K | $59.21 | -$1.99M | SELL | -1.89% | 95.93K | Feb 18 - Feb 19 |
FAQ
L'insider trading è legale?
L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.
Quali sono alcuni esempi di manipolazione del mercato?
L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.
Sfoglia insider trading su tutte le azioni.